Leading AI biotech company Genetica has launched the decentralized science platform GenomicDAO to empower billions of people to join forces for the advancement of Precision Medicine.
GenomicDAO breaks free from the centralization of modern medicine R&D by establishing a community that initiates, drives, and governs precision medicine initiatives. Members are incentivized for supporting GenomicDAO precision medicine initiatives.
Understanding GenomicDAO platform
GenomicDAO designs a platform for three key stakeholders connecting:
-
Communities that initiate, drive, and govern precision medicine research for all members at any cost.
-
Research groups that will advance noble healthcare causes based on actual medical needs
-
A direct-to-consumer marketplace for end products, including genetic insights, personalized recommendations, and precision medicine drugs
GenomicDAO revenue derives from direct-to-consumer products. Proceeds from the marketplace are then used to buy back GenomicDAO tokens, thereby increasing the value of the project exponentially and benefiting investors.
GenomicDAO has kicked off its first initiative - Stroke Prevention with its governance and utility token listing set on February 20.
Stroke-Prevention GenomicDAO presents its unique BEP20-based governance and utility token $PCSP, which allows investors to become rightful stakeholders, participate in GenomicDAO’s liquidity, and receive active voting power on significant business direction, reaping the financial and medical benefits and successes.
PCSP: Governance and Utility token of Stroke-Prevention GenomicDAO
A PCSP token, a BEP20-based security token, is a digital asset purpose-built for our platform. $PCSP tokens are a payment method, a means for investors to receive rewards from liquidity and special programs, and a way to exercise voting rights.
PCSP Token Info:
-
Token Name: Stroke-Prevention GenomicDAO Token
-
Token Symbol: PCSP
-
Network: BEP-20
-
Total Supply: 1,000,000,000
-
Public Sale: No
Token Allocation:
-
Community Development: 100,000,000
-
Developer Endowment: 100,000,000
-
Strategic Partners: 50,000,000
-
Liquidity: 50,000,000
-
Team: 100,000,000
-
Advisor: 50,000,000
-
R&D: 150,000,000
-
Reserved for GenomicDAO's next stage evolution: 100,000,000
-
GenomicDAO Launchpad: 300,000,000
Stroke Prevention is the first subsidiary DAO under the GenomicDAO ecosystem to help create awareness and initiate R&D for ischemic stroke.
Stroke-Prevention GenomicDAO will officially list $PCSP on February 20.
About GenomicDAO:
GenomicDAO is a decentralized science platform built by biotech company Genetica to empower billions of people to join forces for the advancement of precision medicine.
Social Platforms:
Website: https://genomicdao.com/
Learn more about Genetica: https://genetica.asia/
Telegram Group: https://t.me/GenomicDAOgroup
Media Details:
Name GENOMICA PTE. LTD.
Website: https://genomicdao.com/
Email: bob@genomicdao.com
City: Singapore
Country: Singapore
There is no offer to sell, no solicitation of an offer to buy, and no recommendation of any security or any other product or service in this article. Moreover, nothing contained in this PR should be construed as a recommendation to buy, sell, or hold any investment or security, or to engage in any investment strategy or transaction. It is your responsibility to determine whether any investment, investment strategy, security, or related transaction is appropriate for you based on your investment objectives, financial circumstances, and risk tolerance. Consult your business advisor, attorney, or tax advisor regarding your specific business, legal, or tax situation. Newsroom: abrelease.submitmypressrelease.com
Source: Prodigy.press
Release ID: 522130
